New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Columbia neuroscientists have identified brain-cell circuitry in fruit flies that converts waves of light entering the eye into color perceptions in the brain.
Columbia neuroscientists found that the mouse brain can direct the body's immune system to an unexpected degree, a discovery that could lead to new therapies for many immune disorders.
A study co-led by Columbia scientists suggests a nutrient transporter located at the blood-brain barrier could be commandeered to sneak therapeutic drugs into the brain.
Research from Columbia neuroscientists shows that a previously held bias can be set aside so that the brain can apply logical, mathematical reasoning to the decision at hand.
A Mailman study of more than 1 million pregnancies in Finland reports that prenatal exposure to elevated levels of DDT is associated with an increased risk for autism.
A new clinical trial suggests that donepezil does not improve cognitive performance in people with mild cognitive impairment who also have clinical depression.
New brain cells born during adulthood increase resilience to stress by dampening activity in the brain’s hippocampus, finds a new study from researchers in Columbia Psychiatry.
In one of the first studies of its kind, Columbia’s Philip De Jager shows how "big data" analyses may lead to new treatment strategies for Alzheimer's disease.